Production of recombinant soluble dimeric C-type lectin-like receptors of rat natural killer cells.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
28 11 2019
Historique:
received: 25 03 2019
accepted: 14 10 2019
entrez: 30 11 2019
pubmed: 30 11 2019
medline: 5 11 2020
Statut: epublish

Résumé

Working at the border between innate and adaptive immunity, natural killer (NK) cells play a key role in the immune system by protecting healthy cells and by eliminating malignantly transformed, stressed or virally infected cells. NK cell recognition of a target cell is mediated by a receptor "zipper" consisting of various activating and inhibitory receptors, including C-type lectin-like receptors. Among this major group of receptors, two of the largest rodent receptor families are the NKR-P1 and the Clr receptor families. Although these families have been shown to encode receptor-ligand pairs involved in MHC-independent self-nonself discrimination and are a target for immune evasion by tumour cells and viruses, structural mechanisms of their mutual recognition remain less well characterized. Therefore, we developed a non-viral eukaryotic expression system based on transient transfection of suspension-adapted human embryonic kidney 293 cells to produce soluble native disulphide dimers of NK cell C-type lectin-like receptor ectodomains. The expression system was optimized using green fluorescent protein and secreted alkaline phosphatase, easily quantifiable markers of recombinant protein production. We describe an application of this approach to the recombinant protein production and characterization of native rat NKR-P1B and Clr-11 proteins suitable for further structural and functional studies.

Identifiants

pubmed: 31780667
doi: 10.1038/s41598-019-52114-8
pii: 10.1038/s41598-019-52114-8
pmc: PMC6882821
doi:

Substances chimiques

Calcitonin Receptor-Like Protein 0
Calcrl protein, rat 0
NK Cell Lectin-Like Receptor Subfamily B 0
Recombinant Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

17836

Commentaires et corrections

Type : ErratumIn

Références

Immunol Rev. 2015 Sep;267(1):137-47
pubmed: 26284475
Cell. 2017 Mar 23;169(1):58-71.e14
pubmed: 28340350
Acta Crystallogr D Biol Crystallogr. 2006 Oct;62(Pt 10):1243-50
pubmed: 17001101
J Immunol. 2012 Nov 15;189(10):4881-9
pubmed: 23071282
J Immunol. 2015 Mar 15;194(6):2909-18
pubmed: 25681346
Nat Rev Immunol. 2003 Oct;3(10):781-90
pubmed: 14523385
J Mass Spectrom. 2009 Nov;44(11):1571-8
pubmed: 19551705
Front Immunol. 2013 Nov 07;4:362
pubmed: 24223577
Science. 1990 Sep 14;249(4974):1298-300
pubmed: 2399464
J Mol Biol. 1996 Jun 21;259(4):774-91
pubmed: 8683582
J Mol Recognit. 2000 Nov-Dec;13(6):325-51
pubmed: 11114067
FEBS J. 2008 Nov;275(22):5589-606
pubmed: 18959746
Nat Immunol. 2008 May;9(5):495-502
pubmed: 18425106
Biotechnol Bioeng. 2005 May 5;90(3):332-44
pubmed: 15803471
Structure. 2007 Mar;15(3):267-73
pubmed: 17355862
J Immunol. 2005 Dec 15;175(12):7796-9
pubmed: 16339513
Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3527-32
pubmed: 14990792
J Immunol. 2005 Dec 15;175(12):7791-5
pubmed: 16339512
Biophys J. 2000 Mar;78(3):1606-19
pubmed: 10692345
J Exp Med. 1989 Apr 1;169(4):1373-89
pubmed: 2466943
Nat Commun. 2018 Nov 5;9(1):4623
pubmed: 30397201
Q Rev Biophys. 2002 Nov;35(4):369-430
pubmed: 12621861
Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3192-7
pubmed: 16492762
Nucleic Acids Res. 2002 Jan 15;30(2):E9
pubmed: 11788735
Biotechnol Bioeng. 2008 Sep 1;101(1):182-9
pubmed: 18454496
Biotechnol Bioeng. 2005 Feb 20;89(4):400-6
pubmed: 15619325
Trends Biochem Sci. 2001 Nov;26(11):687-9
pubmed: 11701329
Oncoimmunology. 2015 Apr 8;4(8):e1026503
pubmed: 26405582
Biotechnol Adv. 2010 May-Jun;28(3):385-94
pubmed: 20156545
J Mol Model. 2011 Jun;17(6):1353-70
pubmed: 20839018
Annu Rev Immunol. 2005;23:225-74
pubmed: 15771571
Eur J Immunol. 2009 Feb;39(2):541-51
pubmed: 19130483
Cancer Res. 2018 Jul 1;78(13):3589-3603
pubmed: 29691253
Nature. 1986 Feb 20-26;319(6055):675-8
pubmed: 3951539
Biochim Biophys Acta. 2007 Sep;1767(9):1073-101
pubmed: 17692815
Prog Biophys Mol Biol. 2000;74(3-5):141-73
pubmed: 11226511
J Innate Immun. 2015;7(6):584-600
pubmed: 26044139
J Struct Biol. 2011 Sep;175(3):434-41
pubmed: 21600988
J Immunol. 2012 May 15;188(10):4980-91
pubmed: 22491247
Cancer Res. 2007 Apr 15;67(8):3540-4
pubmed: 17440061
Biopolymers. 1983 Dec;22(12):2577-637
pubmed: 6667333
Cancer Res. 2010 Sep 15;70(18):7102-13
pubmed: 20823164
J Proteomics. 2019 Mar 30;196:162-172
pubmed: 30414947
Acta Crystallogr D Biol Crystallogr. 2015 Mar;71(Pt 3):578-91
pubmed: 25760607
Blood. 2015 Apr 2;125(14):2217-27
pubmed: 25612621
Nat Immunol. 2003 Aug;4(8):801-7
pubmed: 12858173
Immunol Res. 2006;35(1-2):13-26
pubmed: 17003506
Nat Immunol. 2008 May;9(5):503-10
pubmed: 18425107
J Immunol. 2006 Jun 15;176(12):7511-24
pubmed: 16751398
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13419-24
pubmed: 12370423
Biochemistry. 1990 Sep 18;29(37):8771-9
pubmed: 2271555
Biophys Chem. 1999 Jul 19;80(1):7-20
pubmed: 10457593
Oncotarget. 2016 Oct 18;7(42):68650-68661
pubmed: 27626681
Anal Biochem. 2003 Sep 1;320(1):104-24
pubmed: 12895474
Immunity. 2007 May;26(5):617-27
pubmed: 17462921
Methods Mol Biol. 2002;173:57-74
pubmed: 11859779

Auteurs

Ondřej Vaněk (O)

Department of Biochemistry, Faculty of Science, Charles University, Hlavova 2030/8, 12840, Prague, Czech Republic. ondrej.vanek@natur.cuni.cz.

Petra Celadova (P)

Department of Biochemistry, Faculty of Science, Charles University, Hlavova 2030/8, 12840, Prague, Czech Republic.

Ondřej Skořepa (O)

Department of Biochemistry, Faculty of Science, Charles University, Hlavova 2030/8, 12840, Prague, Czech Republic.

Jan Bláha (J)

Department of Biochemistry, Faculty of Science, Charles University, Hlavova 2030/8, 12840, Prague, Czech Republic.
EMBL Hamburg, c/o DESY, Building 25A, Notkestraße 85, 22603, Hamburg, Germany.

Barbora Kalousková (B)

Department of Biochemistry, Faculty of Science, Charles University, Hlavova 2030/8, 12840, Prague, Czech Republic.

Anna Dvorská (A)

Department of Biochemistry, Faculty of Science, Charles University, Hlavova 2030/8, 12840, Prague, Czech Republic.

Edita Poláchová (E)

Department of Biochemistry, Faculty of Science, Charles University, Hlavova 2030/8, 12840, Prague, Czech Republic.

Helena Pucholtová (H)

Department of Biochemistry, Faculty of Science, Charles University, Hlavova 2030/8, 12840, Prague, Czech Republic.

Daniel Kavan (D)

Department of Biochemistry, Faculty of Science, Charles University, Hlavova 2030/8, 12840, Prague, Czech Republic.
Institute of Microbiology, The Czech Academy of Sciences, Vídeňská 1083, 14220, Prague, Czech Republic.

Petr Pompach (P)

Institute of Microbiology, The Czech Academy of Sciences, Vídeňská 1083, 14220, Prague, Czech Republic.

Kateřina Hofbauerová (K)

Institute of Microbiology, The Czech Academy of Sciences, Vídeňská 1083, 14220, Prague, Czech Republic.
Institute of Physics, Faculty of Mathematics and Physics, Charles University, Ke Karlovu 5, 12116, Prague, Czech Republic.

Vladimír Kopecký (V)

Institute of Physics, Faculty of Mathematics and Physics, Charles University, Ke Karlovu 5, 12116, Prague, Czech Republic.

Aruz Mesci (A)

Department of Immunology, University of Toronto, 1 King's College Circle, M5S 1A8, Toronto, ON, Canada.

Sebastian Voigt (S)

Department of Infectious Diseases, Robert Koch Institute, Seestraße 10, 13353, Berlin, Germany.

James R Carlyle (JR)

Department of Immunology, University of Toronto, 1 King's College Circle, M5S 1A8, Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH